Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Investigating the necessity of elastic restraints after hip and knee surgery

Official title: Are Elastic Restraints Still Necessary in Improved Rehabilitation Programs After Hip and Knee Prosthetic Surgery?

Run by Clinique Pasteur Lanroze · NCT06563531 · Data updated 2026-11-12

This study is testing if using just medication is as good as using both medication and elastic straps to prevent blood clots in people having hip or knee replacement surgery.

More Arthroplasty Complications trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment1274 (estimated)
SponsorClinique Pasteur Lanroze
Academic / other
Locations1 site (Brest)
StatusRecruiting
StartedNovember 15, 2024
Main results expectedJune 15, 2027
Study endsJuly 15, 2027
Registry record updatedApril 6, 2026
Trial IDNCT06563531 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients scheduled for first-line, non-traumatic total hip or knee arthroplasty who are part of an Enhanced Rehabilitation after Surgery protocol.

Probably not a fit

Patients with pre-existing co-morbidities requiring long-term anticoagulation or those with coagulation disorders will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate whether pharmacological prophylaxis alone is as effective as a combination of pharmacological and mechanical prophylaxis (using elastic restraints) in preventing venous thrombosis after hip and knee arthroplasty. The study will involve a multicenter, prospective, randomized design, focusing on patients undergoing first-line, non-traumatic total hip or knee replacements as part of an Enhanced Rehabilitation after Surgery protocol. By comparing these two approaches, the trial seeks to determine the non-inferiority of pharmacological treatment without the use of elastic compression devices. The findings could provide valuable insights into optimizing postoperative care and reducing unnecessary interventions.

Why it matters

Potential benefit: If successful, this study could lead to more streamlined postoperative care for patients undergoing hip and knee replacements, potentially reducing the need for elastic restraints.

How similar studies have gone: While several studies have explored the use of elastic restraints in thromboembolism prevention, this specific investigation into the non-inferiority of pharmacological treatment without mechanical devices is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* first line and non-traumatic total hip or knee arthroplasty
* Patient included in an Enhanced Rehabilitation after Surgery (ERS) or "fast-track" protocol, or scheduled as an outpatient.

Exclusion Criteria:

* Patient requiring long-term anticoagulation for pre-existing co-morbidity
* Patients with coagulation disorders (hypercoagulability)
* Patient undergoing thrombogenic pharmacological treatment
* History of obliterative arteriopathy of the lower limbs
* Arterial disease
* Obesity
* Heart failure
* Chronic bronchopneumopathy
* Lymphedema
* Chronic inflammatory disease
* Permanent wearing of elastic restraints
* Proximal or distal arterial bypass surgery
* Creatinine clearance \< 15 ml/min
* Inability to give consent
* Revision surgery for hip or knee prosthesis
* Metastatic cancer
* Life expectancy less than 3 months
* Allergy to socks or compression stockings
* Patients presenting one or more exclusion criteria for the fast-track protocol (severe or poorly-balanced associated conditions such as diabetes or immunodepression, inability to contact the doctor or hospital department if necessary, pre-operative ASA score greater than or equal to 4).
* Adults under guardianship or curatorship
* Vulnerable persons in accordance with article L1121-6 of the CSP (French Public Health Code)

Where it's running

  • Clinique Pasteur Lanroze
    Brest, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.